Minneapolis, MN6 Active Studies

Peripheral Artery Disease Clinical Trials in Minneapolis, MN

Find 6 actively recruiting peripheral artery disease clinical trials in Minneapolis, MN. Connect with local research sites and explore new treatment options.

6
Active Trials
3
Sponsors
1,352
Enrolling

Recruiting Peripheral Artery Disease Studies in Minneapolis

About Peripheral Artery Disease Clinical Trials in Minneapolis

Peripheral artery disease (PAD) is a circulatory condition where narrowed arteries reduce blood flow to the limbs, especially the legs. Common symptoms include leg pain when walking (claudication). Treatment includes lifestyle changes, medications, and sometimes procedures to improve blood flow.

There are currently 6 peripheral artery disease clinical trials recruiting participants in Minneapolis, MN. These studies are seeking a combined 1,352 participants. Research is being sponsored by SurModics, Inc., Northwestern University, University of Minnesota. Clinical trial participation is free and participants receive study-related medical care at no cost.

Peripheral Artery Disease Clinical Trials in Minneapolis — FAQ

Are there peripheral artery disease clinical trials in Minneapolis?

Yes, there are 6 peripheral artery disease clinical trials currently recruiting in Minneapolis, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Minneapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you about next steps.

Are clinical trials in Minneapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Minneapolis studies also compensate for your time and travel.

What peripheral artery disease treatments are being tested?

The 6 active trials in Minneapolis are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral artery disease.

Data updated July 19, 2026 from ClinicalTrials.gov